Cynata Therapeutics (CYP)
Cynata Therapeutics Ltd. is an stem cell and regenerative medicine company, which develops a therapeutic stem cell platform technology, Cymerus, using discoveries made at the University of Wisconsin-Madison. The company was founded on March 12, 2003 and is headquartered in Armadale, Australia.
|Market Price at 12-12-2017||$0.62|
|Price to Earnings Ratio||-10.36|
|Market Capitalisation||$55.84 (million)|
|Return on Equity (ROE)||-32.9%|